HB 247

  • Florida House Bill
  • 2023 Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Sickle Cell Program

Bill Subjects

Subject Index

Abstract

Sickle Cell Program; Requires DOH to establish grant program for prevention, care, & treatment of sickle cell disease or sickle cell trait or sickle cell trait carriers & for educational programs & develop application criteria & standards of eligibility for such program; requires department to develop & maintain voluntary registry & to conduct specified study; provides rulemaking authority to department.

Bill Sponsors (3)

Votes


Actions


May 05, 2023

House

Died in Health Care Appropriations Subcommittee

Apr 10, 2023

House

Added to Health Care Appropriations Subcommittee agenda

Mar 30, 2023

House

Referred to Health Care Appropriations Subcommittee

House

Now in Health Care Appropriations Subcommittee

House

Referred to Health & Human Services Committee

Mar 29, 2023

House

Reported out of Healthcare Regulation Subcommittee

House

Laid on Table under Rule 7.18(a)

House

CS Filed

House

1st Reading (Committee Substitute 1)

Mar 28, 2023

House

Favorable with CS by Healthcare Regulation Subcommittee

Mar 24, 2023

House

Added to Healthcare Regulation Subcommittee agenda

Mar 07, 2023

House

1st Reading (Original Filed Version)

Jan 25, 2023

House

Now in Healthcare Regulation Subcommittee

House

Referred to Health & Human Services Committee

House

Referred to Health Care Appropriations Subcommittee

House

Referred to Healthcare Regulation Subcommittee

Jan 18, 2023

House

Filed

Bill Text

Bill Text Versions Format
H 247 Filed PDF
H 247 c1 PDF

Related Documents

Document Format
907685 - Amendment to H 247 Filed PDF
Bill Analysis -- Health Care Appropriations Subcommittee (Post-Meeting) (4/11/2023 9:11 AM)
Bill Analysis -- Healthcare Regulation Subcommittee (Post-Meeting) (3/29/2023 3:40 PM)

Sources

Data on Open States is updated periodically throughout the day from the official website of the Florida Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.